Tag Archives: China gives the go-ahead for human trials of BioNTech’s COVID vaccine candidate

China has approved an early-stage trial in humans of German firm BioNTech’s experimental COVID-19 vaccine, its local partner Shanghai Fosun Pharmaceutical said on Thursday. The potential vaccine is one of the two most advanced candidates that BioNTech is working on with its partner Pfizer Inc and they received “fast track” status this week from the U.S. Food and Drug Administration which is …

Read More »